Read more about Avita Medical – Results of Annual General Meeting
Leading Australian life sciences investment group BioScience Managers today confirmed it will vote against the remuneration report of spray-on skin company Avita Medical Limited (ASX:AVH) at the company’s AGM on Friday 22 November.
Read more about Avita Medical Facing First Strike
Financial report 2013 link here.
Read more about Avita Medical Annual Report to shareholders
Nexus6 Ltd, a digital health company dedicated to improving respiratory care, today announced three appointments to its senior management team following the Company’s successful US$3.6m financing earlier in 2013.
Read more about Nexus6 Steps Up its Global Presence with Three New Appointments
Link to the investor presentation here.
Read more about Alchemia Ltd Investor Presentation September 2013
Pharmaceutical company Pharmaxis today announced the retirement of two non‐executive directors, Dr John Villiger and Mr Richard van den Broek.
Read more about 19.09.2013 – Pharmaxis Announces Two Board Retirements
Alchemia Limited, (ASX – ACL) (Alchemia or the Company), an Australian drug discovery and development company, announces today its results for the financial year 2013. In the year, the Company saw significant progress across its key assets...
Avita Medical ASX announcement link here.
Read more about Avita Medical Appendix 4E Year Ending 30 June 2013
Pharmaceutical company Pharmaxis (ASX:PXS) today announced it will scale back resources and investments dedicated to the launch of Bronchitol in France due to delays in reaching an agreement with French authorities on a reimbursed price for the cystic fibrosis treatment.
Read more about Pharmaxis Announces Delay to French Pricing for Bronchitol